Is VYNE up or down today?
VYNE is up 12.22% today, last at 28.56. This stock moved +12.22% versus the prior close.
VYNE · VYNE
VYNE (VYNE) is trading at 28.56, up 12.22% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 18 headlines skew mixed. Macro/Market and M&A themes dominated coverage. Stories with measurable price impact averaged +10.50% — the market reacted positively.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
VYNE is up 12.22% today, last at 28.56. This stock moved +12.22% versus the prior close.
Over the past 7 days, 18 headlines skew mixed. Macro/Market and M&A themes dominated coverage. Stories with measurable price impact averaged +10.50% — the market reacted positively. Dominant story: Book value per share of VYNE Therapeutics Inc. – NASDAQ:YARW - TradingView (1 source, bullish) RSI is 69 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 42% of recent mentions lean bullish — mixed social mood.
Loaded: Jan 2026 – Jul 2026 (120 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: VYNE
75/ 100 index
-13.8% vs start of window
Based on 11,521 mentions over 30d
Book value per share of VYNE Therapeutics Inc. – NASDAQ:YARW - TradingView
RTW Biotech's Portfolio Company Completes Merger with Vyne Therapeutics - marketscreener.com
Yarrow Bioscience, RTW Biotech Opportunities Ltd's Seventh Portfolio Firm, Debuts on Nasdaq Post VYNE Merger and $200M Funding - kalkinemedia.com
Enterprise value to revenue forward of VYNE Therapeutics Inc. – NASDAQ:YARW - TradingView
Yarrow Bioscience closes VYNE merger and $200 million financing - Quiver Quantitative